Anxiety disorders are associated with quality of life impairment in patients with insulin-dependent type 2 diabetes: a case-control study.
暂无分享,去创建一个
H. Abelaira | G. Réus | J. Quevedo | L. Ceretta | L. Jornada | R. Ceretta | Morgana V. Neotti | M. Schwalm | Cristiane D. Tomazzi | Karina G. Gulbis | M. A. Santos
[1] H. Abelaira,et al. Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients , 2012, Acta Diabetologica.
[2] G. Hu,et al. Glycosylated Hemoglobin in Relationship to Cardiovascular Outcomes and Death in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis , 2012, PloS one.
[3] J. Lewko,et al. Relationship between the occurrence of symptoms of anxiety and depression, quality of life, and level of acceptance of illness in patients with type 2 diabetes. , 2012, Saudi medical journal.
[4] A. K. Khuwaja.,et al. Anxiety and depression among outpatients with type 2 diabetes: A multi-centre study of prevalence and associated factors , 2010, Diabetology & metabolic syndrome.
[5] S. Chong,et al. Impact of depression on health related quality of life in patients with diabetes. , 2010, Annals of the Academy of Medicine, Singapore.
[6] A. K. Khuwaja.,et al. Gender differences and clustering pattern of behavioural risk factors for chronic non-communicable diseases: community-based study from a developing country. , 2010, Chronic illness.
[7] J. Mishra,et al. Psychiatric morbidity among diabetic patients: A hospital-based study , 2010, Industrial psychiatry journal.
[8] L. Egede,et al. The effect of depression on self-care behaviors and quality of care in a national sample of adults with diabetes. , 2009, General hospital psychiatry.
[9] F. Pouwer,et al. Depression and Quality of Life in Patients with Diabetes: A Systematic Review from the European Depression in Diabetes (EDID) Research Consortium , 2009, Current diabetes reviews.
[10] Deborah E. Jones,et al. Depression, quality of life, and glycemic control in individuals with type 2 diabetes , 2009, Journal of the American Academy of Nurse Practitioners.
[11] P. Corcoran,et al. Anxiety and depression symptoms in patients with diabetes , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[12] K. Chou,et al. A systematic review of the efficacy of non-pharmacological treatments for depression on glycaemic control in type 2 diabetics. , 2008, Journal of clinical nursing.
[13] D. D. de Quervain,et al. Glucocorticoids reduce phobic fear in humans. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[14] Nils Welsh,et al. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. , 2005, Diabetes.
[15] Evette Ludman,et al. The association of comorbid depression with mortality in patients with type 2 diabetes. , 2005, Diabetes care.
[16] Neil R. Powe,et al. Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.
[17] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[18] Rachel Jenkins,et al. Risk factors, prevalence, and treatment of anxiety and depressive disorders in Pakistan: systematic review , 2004, BMJ : British Medical Journal.
[19] K. Freedland,et al. Prevalence of anxiety in adults with diabetes: a systematic review. , 2002, Journal of psychosomatic research.
[20] K. Butcher,et al. The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome , 2002, Journal of Clinical Neuroscience.
[21] K. Freedland,et al. Anxiety and Poor Glycemic Control: A Meta-Analytic Review of the Literature , 2002, International journal of psychiatry in medicine.
[22] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[23] F. Messerli,et al. Diabetes, hypertension, and cardiovascular disease: an update. , 2001, Hypertension.
[24] K. Freedland,et al. Association of Depression and Diabetes Complications: A Meta-Analysis , 2001, Psychosomatic medicine.
[25] E. Frohlich,et al. Diabetes, Hypertension, and Cardiovascular Disease: An Update , 2001, Hypertension.
[26] P. Amorim. Mini International Neuropsychiatric Interview (MINI): validacao de entrevista breve para diagnostico de transtornos mentais , 2000 .
[27] Guilherme Bergmann Borges Vieira,et al. Aplicação da versão em português do instrumento de avaliação de qualidade de vida da Organização Mundial da Saúde (WHOQOL-100) , 1999 .
[28] Richard Barnett. Diabetes , 1904, The Lancet.
[29] Teven,et al. EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES AND NEPHROPATHY EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY , 2001 .
[30] M. Xavier,et al. [Application of the Portuguese version of the instrument for the assessment of quality of life of the World Health Organization (WHOQOL-100)]. , 1999, Revista de saude publica.